These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11272899)

  • 1. Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.
    Cui X; Feiner H; Lin Z; Li H
    J Mol Diagn; 2000 Feb; 2(1):29-36. PubMed ID: 11272899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer.
    Xie B; Freudenheim JL; Cummings SS; Singh B; He H; McCann SE; Moysich KB; Shields PG
    Carcinogenesis; 2006 Feb; 27(2):307-10. PubMed ID: 16113052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiplexed methylation analysis--a new technology to analyse the methylation pattern of laser microdissected cells of normal breast tissue, DCIS and invasive ductal carcinoma of the breast].
    Dietrich D; Schuster M; Lesche R; Haedicke W; Kristiansen G
    Verh Dtsch Ges Pathol; 2007; 91():197-207. PubMed ID: 18314615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
    Koreth J; Bethwaite PB; McGee JO
    J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET).
    Jaremko M; Justenhoven C; Abraham BK; Schroth W; Fritz P; Brod S; Vollmert C; Illig T; Brauch H
    Hum Mutat; 2005 Mar; 25(3):232-8. PubMed ID: 15706592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
    J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification testing in breast cancer by multiplex ligation-dependent probe amplification of microdissected tissue.
    Moelans CB; de Weger RA; van Diest PJ
    Methods Mol Biol; 2011; 755():107-18. PubMed ID: 21761298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA content and cell number determination in microdissected samples of breast carcinoma in situ.
    Blumenstein R; Dias M; Russo IH; Tahin Q; Russo J
    Int J Oncol; 2002 Aug; 21(2):447-50. PubMed ID: 12118344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality analysis of intraductal proliferative lesions using the human androgen receptor assay.
    Li H; Chen Q; Zhu R; Gu DH; Zhu HG
    Neoplasma; 2007; 54(6):490-4. PubMed ID: 17949232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the HER2/neu gene amplification in microdissected breast cancer tumour samples.
    Seth RM; Burger AM; Kahn HJ
    Anticancer Res; 2006; 26(2A):927-31. PubMed ID: 16619488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.